A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these exchange-traded funds bought roughly $65 million worth of CRISPR Therapeutics AG (NASDAQ: CRSP | CRSP Price Prediction), as the prices of these funds were fairly positive on Wednesday. Note that their performance is mixed in the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 150,210 shares of CRISPR, and ARK Innovation ETF (NYSEARCA: ARKK) bought 527,747 shares. At Wednesday’s closing prices, this would have valued the sales at roughly $65.6 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The innovation ETF is up about 10% and the other is down 1% in the past year.
Note that these same funds also purchased nearly $40 million in CRISPR shares earlier this week.
[nativounit]
Check out all the ARK Invest trades for Wednesday as well:
| Fund | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKG | Buy | CRSP | CRISPR THERAPEUTICS | 150,210 |
| ARKG | Buy | DYNS | DYNAMICS SPECIAL PURPOSE | 577 |
| ARKG | Buy | NTLA | INTELLIA THERAPEUTICS | 51,559 |
| ARKG | Buy | QSI | QUANTUM-SI | 19,900 |
| ARKG | Buy | SLGC | SOMALOGIC | 399,610 |
| ARKG | Buy | VCYT | VERACYTE | 11,037 |
| ARKG | Sell | VEEV | VEEVA SYSTEMS | 81,531 |
| ARKK | Buy | CRSP | CRISPR THERAPEUTICS | 527,747 |
| ARKK | Buy | BEAM | BEAM THERAPEUTICS | 18,429 |
| ARKK | Sell | PRLB | PROTO LABS | 119,571 |
| ARKK | Sell | SPOT | SPOTIFY TECHNOLOGY | 128,790 |
| ARKK | Sell | U | UNITY SOFTWARE | 142,810 |
| ARKQ | Buy | MKFG | MARKFORGED | 127,526 |
| ARKQ | Buy | TWOU | 2U | 1,330 |
| ARKQ | Buy | VLD | VELO3D | 102,790 |
| ARKW | Buy | GENI | GENIUS SPORTS | 21,618 |
| ARKX | Buy | MKFG | MARKFORGED | 199,719 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
[recirclink id=971834][wallst_email_signup]